全文获取类型
收费全文 | 1578863篇 |
免费 | 128723篇 |
国内免费 | 7034篇 |
专业分类
耳鼻咽喉 | 19665篇 |
儿科学 | 49166篇 |
妇产科学 | 40636篇 |
基础医学 | 215522篇 |
口腔科学 | 41547篇 |
临床医学 | 144805篇 |
内科学 | 326767篇 |
皮肤病学 | 35989篇 |
神经病学 | 132721篇 |
特种医学 | 65565篇 |
外国民族医学 | 288篇 |
外科学 | 247623篇 |
综合类 | 34678篇 |
现状与发展 | 3篇 |
一般理论 | 671篇 |
预防医学 | 126698篇 |
眼科学 | 33445篇 |
药学 | 110089篇 |
6篇 | |
中国医学 | 2600篇 |
肿瘤学 | 86136篇 |
出版年
2021年 | 13534篇 |
2019年 | 13651篇 |
2018年 | 18810篇 |
2017年 | 14720篇 |
2016年 | 17269篇 |
2015年 | 19525篇 |
2014年 | 27412篇 |
2013年 | 40443篇 |
2012年 | 52007篇 |
2011年 | 55646篇 |
2010年 | 33979篇 |
2009年 | 32847篇 |
2008年 | 51500篇 |
2007年 | 54799篇 |
2006年 | 55533篇 |
2005年 | 54101篇 |
2004年 | 51359篇 |
2003年 | 49586篇 |
2002年 | 47130篇 |
2001年 | 68495篇 |
2000年 | 69922篇 |
1999年 | 59232篇 |
1998年 | 19594篇 |
1997年 | 17302篇 |
1996年 | 18052篇 |
1995年 | 18058篇 |
1994年 | 16752篇 |
1993年 | 15712篇 |
1992年 | 48535篇 |
1991年 | 47147篇 |
1990年 | 45209篇 |
1989年 | 42970篇 |
1988年 | 39901篇 |
1987年 | 39203篇 |
1986年 | 36974篇 |
1985年 | 35793篇 |
1984年 | 27647篇 |
1983年 | 23360篇 |
1982年 | 15447篇 |
1981年 | 14028篇 |
1980年 | 13064篇 |
1979年 | 24475篇 |
1978年 | 18090篇 |
1977年 | 15240篇 |
1976年 | 13976篇 |
1975年 | 14408篇 |
1974年 | 16845篇 |
1973年 | 16095篇 |
1972年 | 14730篇 |
1971年 | 13497篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Lalia Y. Ibrahim Krank P. DiFilippo Geremy E. Steed Manuel D. Cerqueira 《Journal of nuclear cardiology》2006,13(6):855-866
Conclusion Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve
high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed
to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially
if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable
problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the
available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality
control to obtain the best possible images. 相似文献
32.
33.
34.
James R. Gill 《Forensic science, medicine, and pathology》2006,2(1):29-32
On September 11, 2001 two hijacked airplanes struck the Twin Towers at the World Trade Center in New York City. All of the
remains (19,915) were examined by the Office of Chief Medical Examiner (OCME) of New York City. The major goals of the OCME
were to accurately identify the decedents and to promptly issue death certificates. As of September 2005, there were 1594
identifications of a total of 2749 people reported missing. Of these, 976 were identified by a single means, which included
DNA analysis in 852 of the victims. Use of legal statues can assist in the timely issuance of death certificates in mass fatalities,
which benefit surviving family members. DNA analysis markedly improves the ability to identify remains and has become the
standard method for identification in these types of disasters. Certain postmortem tissue samples are better suited for DNA
analysis and yield better results than others. 相似文献
35.
D B Irving J L Cook H B Menz 《Journal of Science and Medicine in Sport》2006,9(1-2):11-22; discussion 23-4
36.
Nishard Abdeen Albert Cross Gregory Cron Steven White Thomas Rand David Miller Giles Santyr 《Magnetic resonance in medicine》2006,56(2):255-264
We used the dual capability of hyperpolarized 129Xe for spectroscopy and imaging to develop new measures of xenon diffusing capacity in the rat lung that (analogously to the diffusing capacity of carbon monoxide or DLCO) are calculated as a product of total lung volume and gas transfer rate constants divided by the pressure gradient. Under conditions of known constant pressure breath-hold, the volume is measured by hyperpolarized 129Xe MRI, and the transfer rate is measured by dynamic spectroscopy. The new quantities (xenon diffusing capacity in lung parenchyma (DLXeLP)), xenon diffusing capacity in RBCs (DLXeRBC), and total lung xenon diffusing capacity (DLXe)) were measured in six normal rats and six rats with lung inflammation induced by instillation of fungal spores of Stachybotrys chartarum. DLXeLP, DLXeRBC, and DLXe were 56 +/- 10 ml/min/mmHg, 64 +/- 35 ml/min/mmHg, and 29 +/- 9 ml/min/mmHg, respectively, for normal rats, and 27 +/- 9 ml/min/mmHg, 42 +/- 27 ml/min/mmHg, and 16 +/- 7 ml/min/mmHg, respectively, for diseased rats. Lung volumes and gas transfer times for LP (TtrLP) were 16 +/- 2 ml and 22 +/- 3 ms, respectively, for normal rats and 12 +/- 2 ml and 35 +/- 8 ms, respectively, for diseased rats. Xenon diffusing capacities may be useful for measuring changes in gas exchange associated with inflammation and other lung diseases. 相似文献
37.
38.
Hepatic gene downregulation following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 总被引:1,自引:0,他引:1
Bladimir J Ovando Chad M Vezina Barbara P McGarrigle James R Olson 《Toxicological sciences》2006,94(2):428-438
Chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been shown to lead to the development of hepatotoxicity and carcinogenicity in the liver of female rats. In this study, we investigated hepatic gene downregulation in response to acute and subchronic TCDD exposure. We identified 61 probes which exhibited a downregulation of twofold or greater following subchronic (13 weeks) exposure to TCDD. Comparative analysis of the hepatic expression of these 61 probes was conducted with rats subchronically exposed to PeCDF, PCB126, PCB153, and a mixture of PCB126 and PCB153. PCB153 produced little or no alteration in these probes, while the binary mixture mimicked most closely the downregulation observed with TCDD. To discern if the repression of genes within this probe set occur as a primary response to TCDD exposure, we analyzed the early responsiveness of 11 genes at 6, 24, and 72 h following a single exposure to TCDD. We observed early repression of the 11 genes within this early time course, indicating that the repression of this subset of genes occurs as a primary response to TCDD exposure and not as a secondary response to 13 weeks of subchronic treatment. In addition, the gender, species, and AhR dependence of these responses were also investigated. Gender- and species-dependent repression was observed within this subset of genes. Furthermore, utilizing AhR knockout mice, we were able to determine the AhR-dependent downregulation of seven of 11 genes. Together these results assist efforts to understand the multitude of effects imposed by TCDD and AhR ligands on gene expression. 相似文献
39.
Peter G. Danias Thomas H. Hauser George Katsimaglis Rene M. Botnar Warren J. Manning 《Herz》2003,15(4):90-98
Coronary magnetic resonance angiography (CMRA) is a technique in clinical evolution. Current clinical applications include assessment for coronary anomalies, aneurysms, bypass graft patency, and, in experienced centers, the exclusion of proximal and multivessel coronary artery disease (CAD). As local expertise increases and more extensive multicenter data become available, additional applications will be established. CMRA promises to supplement and in some cases obviate the need for X-ray contrast angiography, and to expand our understanding of the pathophysiology of CAD. Zusammenfassung Die Magnetresonanzangiographie der Koronargefäße (CMRA) ist eine sich ständig weiterentwickelnde Technik. Etablierte Anwendungen sind zurzeit die Beurteilung von koronaren Anomalien, Aneurysmen und der Durchgängigkeit von Bypasses. Auch der Ausschluss proximaler Koronarstenosen und einer koronaren Mehrgefäßerkrankung ist in einigen spezialisierten Zentren möglich. Mit zunehmender Erfahrung der jeweiligen Anwender und der Verfügbarkeit von Ergebnissen großer multizentrischer Studien können zukünftig weitere klinische Anwendungen etabliert werden. In der Zukunft könnte die CMRA ergänzende Informationen zur Indikationsstellung einer konventionellen Röntgenangiographie bringen und in einigen Fällen diese Untersuchung sogar ersetzen. Die CMRA wird unseren Einblick in die Pathophysiologie der koronaren Herzerkrankung sicher erweitern. 相似文献
40.
A-C Koschker M Fassnacht S Hahner D Weismann B Allolio 《Experimental and clinical endocrinology & diabetes》2006,114(2):45-51
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare and highly malignant tumour with a poor prognosis. Patients present with signs of steroid hormone excess (e.g., Cushing's syndrome) or symptoms due to an abdominal mass. DIAGNOSIS: In case of an adrenal mass, hormonal workup before surgery is required for differential diagnosis, perioperative management, and for follow-up. The imaging of choice is CT or MRI with MRI being of additional use when invasion of big vessels is suspected. Apart from that, the use of 18-FDG-PET is becoming increasingly established. TREATMENT: Surgical resection is the therapeutic option of choice in stages 1 - 3. In stage 4, the adrenolytic compound mitotane is part of the first-line treatment, but often needs to be combined with cytotoxic chemotherapy. Most patients will eventually have a recurrence, so adjuvant treatment (mitotane/tumour bed radiation) has to be considered in high risk patients, even if randomized controlled trials on adjuvant treatment are still lacking. STRUCTURAL PROGRESS: Several national and European structures have recently been established in order to increase our knowledge of ACC, improve therapeutic options and diagnostic procedures, and promote research. GANIMED, as a Germany-wide network of experts on adrenal diseases, has been founded allowing for improved gathering of data and joint studies. ENSAT (European Network for the Study of Adrenal Tumours) has been brought to life, aiming at European standards for therapy, diagnosis and tumour banking. Since 2003, patients can be enrolled in the German ACC Registry. France and Italy have also developed a central registry to collect nationwide data from patients with ACC. For the first time, patients with metastatic/unresectable ACC can participate in a prospective controlled randomized trial comparing two different cytotoxic chemotherapy regimes (FIRM-ACT). 相似文献